Citations (118)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Hannah R. Tierney, Sarah W. Takimoto, Soraya Azari, Scott Steiger & Marlene Martin. (2023) Predictors of Linkage to an Opioid Treatment Program and Methadone Treatment Retention following Hospital Discharge in a Safety-Net Setting. Substance Use & Misuse 58:9, pages 1172-1176.
Read now
Read now
Vi Thi Tuong Vu, Hong Huynh Thi Cam Le, Van Thi Thu Tiêu, Nga Thi Thuy Nguyen, Oanh Thi Kim Doan, Thao Thi Phuong Hoang, Trang Thi Nhu Chu, Dung Van Do & Yatan Pal Singh Balhara. (2023) A retrospective cohort study to assess the dropout rates and its predictors in Ho Chi Minh City’s methadone maintenance program using a stringent criterion. Journal of Substance Use 0:0, pages 1-6.
Read now
Read now
Sandra H. Sulzer, Suzanne Prevedel, Tyson Barrett, Maren Wright Voss, Cassandra Manning & Erin Fanning Madden. (2022) Professional education to reduce provider stigma toward harm reduction and pharmacotherapy. Drugs: Education, Prevention and Policy 29:5, pages 576-586.
Read now
Read now
Xiaohu Xie, Jun Gu, Dingding Zhuang, Xiaoyu Chen, Yun Zhou, Wenwen Shen, Longhui Li, Yue Liu, Wenjin Xu, Qingxiao Hong, Weisheng Chen, Wenhua Zhou & Huifen Liu. (2021) Association Study of Genetic Polymorphisms in GABRD with Treatment Response and Dose in Methadone Maintenance Treatment. Personalized Medicine 18:5, pages 423-430.
Read now
Read now
Divya K. Chandra, Frederick L. Altice, Michael M. Copenhaver, Xin Zhou, Elizabeth Didomizio & Roman Shrestha. (2021) Purposeful Fentanyl Use and Associated Factors among Opioid-Dependent People Who Inject Drugs. Substance Use & Misuse 56:7, pages 979-987.
Read now
Read now
Darshan Singh, Wan Maisarah Kamal, Suresh Narayanan & Balasingam Vicknasingam. (2020) Methamphetamine use and misconceptions among primary and private Methadone Maintenance Treatment (MMT) program attendees in Klang Valley, Malaysia. Journal of Substance Use 25:5, pages 528-534.
Read now
Read now
Marcel A. de Dios, Miguel Ángel Cano, Ellen L. Vaughan, Morgan M. McNeel, Sarah Childress & Raymond Niaura. (2019) Nicotine maintenance for smokers in methadone treatment: a new direction. Addiction Research & Theory 27:4, pages 269-276.
Read now
Read now
Steven L. Proctor, Philip L. Herschman, Ronnie Lee & Albert M. Kopak. (2019) The Role of Patient Payment Method in Premature Discharge from Methadone Maintenance Treatment. Substance Use & Misuse 54:1, pages 97-105.
Read now
Read now
Benjamin Johns, Le Bao Chau, Kieu Huu Hanh, Pham Duc Manh, Hoa Mai Do, Anh Thuy Duong & Long Hoang Nguyen. (2018) Association Between User Fees and Dropout from Methadone Maintenance Therapy: Results of a Cohort Study in Vietnam. Health Systems & Reform 4:2, pages 101-113.
Read now
Read now
Carlos Roncero, Daniel Fuster, Raul Felipe Palma-Álvarez, Laia Rodriguez-Cintas, Nieves Martinez-Luna & F. Javier Álvarez. (2017) HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study. AIDS Care 29:12, pages 1551-1556.
Read now
Read now
Annette Dale-Perera, Farrukh Alam & Peter Barker. (2015) Opioid-dependence treatment in the era of recovery: insights from a UK survey of physicians, patients and out-of-treatment opioid users. Journal of Substance Use 20:5, pages 354-362.
Read now
Read now
Wouter Vanderplasschen, Jan Naert, Freya Vander Laenen & Jessica De Maeyer. (2015) Treatment satisfaction and quality of support in outpatient substitution treatment: opiate users’ experiences and perspectives. Drugs: Education, Prevention and Policy 22:3, pages 272-280.
Read now
Read now
Heide Jackson, Kara Mandell, Kimberly Johnson, Debanjana Chatterjee & David J. Vanness. (2015) Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence. Substance Abuse 36:2, pages 226-231.
Read now
Read now
Hui-Ju Tsai, Sheng-Chang Wang, Sheng-Wen Liu, Ing-Kang Ho, Yao-Sheng Chang, Yu-Ting Tsai, Keh-Ming Lin & Yu-Li Liu. (2014) Assessment of CYP450 Genetic Variability Effect on Methadone Dose and Tolerance. Pharmacogenomics 15:7, pages 977-986.
Read now
Read now
Lin Zhao, William L. Holzemer, Jacqueline P. Tulsky, Mallory O. Johnson & Carol Dawson Rose. (2014) Effect of Methadone Dose on Maintenance Treatment and Health Consequences Among Heroin Addicts in South China. Substance Use & Misuse 49:1-2, pages 13-21.
Read now
Read now
TimothyW. Kinlock, MichaelS. Gordon, RobertP. Schwartz & KevinE. O'Grady. (2013) Individual Patient and Program Factors Related to Prison and Community Treatment Completion in Prison-Initiated Methadone Maintenance Treatment. Journal of Offender Rehabilitation 52:8, pages 509-528.
Read now
Read now
Miriam Adelson, Hon
Wai Wilson, Vong
Yim Mui Celeste, Shirley Linzy, Mary
Jeanne Kreek & Einat Peles. (2013) Methadone Maintenance Treatment Experience in Macao – Prospective Follow-up for Initial 4.5 Years. Journal of Psychoactive Drugs 45:4, pages 313-321.
Read now
Read now
Jinma Ren, Zhen Ning, Carl V. Asche, Minghua Zhuang, Carmen S. Kirkness, Xiangyang Ye, Jie Fu & Qichao Pan. (2013) Trends and predictors in methadone maintenance treatment dropout in Shanghai, China: 2005–2011. Current Medical Research and Opinion 29:7, pages 731-738.
Read now
Read now
Articles from other publishers (100)
Nina A. Cooperman, Shou-En Lu, Adam W. Hanley, Thanusha Puvananayagam, Patricia Dooley-Budsock, Anna Kline & Eric L. Garland. (2024) Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain. JAMA Psychiatry 81:4, pages 338.
Crossref
Crossref
Hamzah Bakouni, Lexie Haquet, M. Eugenia Socias, Bernard Le Foll, Ron Lim, Keith Ahamad & Didier Jutras-Aswad. (2024) Associations of Methadone and BUP/NX Dose Titration Patterns With Retention in Treatment and Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: Secondary Analysis of the OPTIMA Study. Journal of Addiction Medicine 18:2, pages 167-173.
Crossref
Crossref
Jeanette Bowles, Manal Mansoor, Dan Werb, Thomas Kerr & Geoff Bardwell. (2024) A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts. Journal of Substance Use and Addiction Treatment 157, pages 209185.
Crossref
Crossref
Scott Beaumont, Tianna Magel, Scott MacDonald, Scott Harrison, Martin Schechter & Eugenia Oviedo-Joekes. (2024) Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT). Substance Abuse Treatment, Prevention, and Policy 19:1.
Crossref
Crossref
Lucas Wiessing, Prakashini Banka-Cullen, M. Gabriela Barbaglia, Vendula Belackova, Saed A. S. Belbaisi, Peter Blanken, Patrizia Carrieri, Catherine Comiskey, Daniel Dacosta-Sánchez, Geert Dom, Venus Fabricius, Hugo Faria, Liljana Ignjatova, Nemanja Inić, Britta Jacobsen, Jana D. Javakhishvili, Zuzana Kamendy, Máté Kapitány-Fövény, Anna Kiss, Evi Kyprianou, Kirsten Marchand, Tim Millar, Viktor Mravcik, Naser J. Y. Mustafa, Carlos Nordt, Markus Partanen, Mads Uffe Pedersen, Hanna Putkonen, Mariam Razmadze, Perrine Roux, Bernd Schulte, Paulo Seabra, Luis Sordo, Lisa Strada, Emilis Subata, Esmeralda Thoma, Marta Torrens, Alexander Y. Walley & Ioanna Yiasemi. (2023) Opioid Agonist Maintenance Treatment Outcomes—The OPTIMUS International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report. International Journal of Mental Health and Addiction.
Crossref
Crossref
Kenneth C. Hohmeier, Alina Cernasev, Christina Leibold, Todd M. Moore, Erica Schlesinger, Ileana Arce, Wesley Geminn, Marie Chisholm-Burns & Gerald Cochran. (2023) Patient reported goals for medications for opioid use disorder: A theory of proximal goal attainment. Exploratory Research in Clinical and Social Pharmacy 12, pages 100345.
Crossref
Crossref
Hamzah Bakouni, Christina McAnulty, Ovidiu Tatar, M. Eugenia Socias, Bernard Le Foll, Ron Lim, Keith Ahamad & Didier Jutras‐Aswad. (2023) Associations of methadone and buprenorphine‐naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription‐type opioid use disorders: Exploratory analyses of the OPTIMA study. The American Journal on Addictions 32:5, pages 469-478.
Crossref
Crossref
Jacqueline E. Rudolph, Javier A. Cepeda, Jacquie Astemborski, Gregory D. Kirk, Shruti H. Mehta & Becky L. Genberg. (2023) Trajectories of drug treatment and illicit opioid use in the AIDS Linked to the IntraVenous Experience cohort, 2014–2019. International Journal of Drug Policy 118, pages 104120.
Crossref
Crossref
Charlotte Lanièce Delaunay, Marina B. Klein, Arnaud Godin, Joseph Cox, Nadine Kronfli, Bertrand Lebouché, Carla Doyle & Mathieu Maheu-Giroux. (2023) Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study. International Journal of Drug Policy 116, pages 104026.
Crossref
Crossref
Riley McNair, Mark Monaghan & Paul Montgomery. (2023) Heroin assisted treatment for key health outcomes in people with chronic heroin addictions: A context-focused systematic review. Drug and Alcohol Dependence 247, pages 109869.
Crossref
Crossref
Alishan S. Amirali, Jacquelin C. Hecker, Hector L. Figueroa-Monsanto, Devin P. Effinger, Rodrigo A. Montoro, Hank P. Jedema, Caleb D. Vogt, Amy Hauck Newman, Charles W. Schindler & Charles W. Bradberry. (2023) Effects of buprenorphine, methadone, and cariprazine on economic choice between remifentanil and food in squirrel monkeys. Addiction Neuroscience 5, pages 100065.
Crossref
Crossref
Elizabeth McCord, Charlotte Van Hale & Yi-Lang Tang. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research
349
367
.
Lynda J. Krasenbaum, Vasantha L. Pedarla, Stephen F. Thompson, Krishna Tangirala, Joshua M. Cohen & Maurice T. Driessen. (2022) A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States. The Journal of Headache and Pain 23:1.
Crossref
Crossref
Xiaohu Xie, Jun Gu, Dingding Zhuang, Yun Zhou, Xiaoyu Chen, Wenwen Shen, Longhui Li, Yue Liu, Wenjin Xu, Qingxiao Hong, Zemin Xu, Weisheng Chen, Wenhua Zhou & Huifen Liu. (2022) Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response. Journal of Clinical Laboratory Analysis 36:11.
Crossref
Crossref
Roman Ivasiy, Lynn M. Madden, Scott O. Farnum, Natalia Shumskaya, Samy J. Galvez de Leon, Daniel J. Bromberg, Ainura Kurmanalieva, Aibek Duishenaliev, Ruslan Tokubaev & Frederick L. Altice. (2022) Implementation opportunities for scaling up methadone maintenance treatment in Kyrgyzstan: Methadone dosage and retention on treatment over two years. Drug and Alcohol Dependence Reports 4, pages 100075.
Crossref
Crossref
Kelli Scott, John Guigayoma, Lawrence A. Palinkas, Francesca L. Beaudoin, Melissa A. Clark & Sara J. Becker. (2022) The measurement-based care to opioid treatment programs project (MBC2OTP): a study protocol using rapid assessment procedure informed clinical ethnography. Addiction Science & Clinical Practice 17:1.
Crossref
Crossref
Marion Selfridge, Kiffer Card, Taylor Kandler, Erin Flanagan, Emily Lerhe, Ash Heaslip, Anne Nguyen, Matthew Moher, Bernie Pauly, Karen Urbanoski & Chris Fraser. (2022) Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency. International Journal of Drug Policy 105, pages 103709.
Crossref
Crossref
Jean Nicolas Westenberg, Andy M. Y. Tai, Julie Elsner, Mostafa M. Kamel, James S. H. Wong, Pouya Azar, Dzung X. Vo, Eva Moore, Nickie Mathew, Vijay Seethapathy, Fiona Choi, Marc Vogel & Reinhard M. Krausz. (2021) Treatment approaches and outcome trajectories for youth with high‐risk opioid use: A narrative review. Early Intervention in Psychiatry 16:3, pages 207-220.
Crossref
Crossref
Tabitha E Moses, Gary L Rhodes, Emytis Tavakoli, Carl W Christensen, Alireza Amirsadri & Mark K Greenwald. (2022) Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program. Substance Abuse: Research and Treatment 16, pages 117822182211383.
Crossref
Crossref
Kristina Chechotka, Jonathan R. Floriani & Marian Fireman. 2022. Transplant Psychiatry. Transplant Psychiatry
153
159
.
James Tidder, Alexander M. Baldacchino & Joseph Tay Wee Teck. 2022. Opioids. Opioids
315
342
.
Hao Wen, Rouhao Chen, Peiming Zhang, Xiaojing Wei, Yu Dong, Shuqi Ge, Wen Luo, Yiping Zhou, Songhua Xiao & Liming Lu. (2021) Acupuncture for Opioid Dependence Patients Receiving Methadone Maintenance Treatment: A Network Meta-Analysis. Frontiers in Psychiatry 12.
Crossref
Crossref
Erick Guerrero, Hortensia Amaro, Yinfei Kong, Tenie Khachikian & Jeanne C. Marsh. (2021) Gender disparities in opioid treatment progress in methadone versus counseling. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Erin Fanning Madden, Bryson T. Christian, Pooja A. Lagisetty, Bradley R. Ray & Sandra H. Sulzer. (2021) Treatment provider perceptions of take-home methadone regulation before and during COVID-19. Drug and Alcohol Dependence 228, pages 109100.
Crossref
Crossref
Nina A. Cooperman, Adam W. Hanley, Anna Kline & Eric L. Garland. (2021) A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being. Journal of Substance Abuse Treatment 127, pages 108468.
Crossref
Crossref
Lindsay Mackay, Paxton Bach, M-J Milloy, Zishan Cui, Thomas Kerr & Kanna Hayashi. (2021) The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs. Drug and Alcohol Dependence 225, pages 108844.
Crossref
Crossref
Wiebke Hansen, Sina Luppus, Romy Barthel, Dae‐In Chang, Julia Broemstrup, Thomas Zwarg, Jo Shibata, Astrid M. Westendorf, Jan Buer & Norbert Scherbaum. (2020)
Heroin‐assisted treatment of heroin‐addicted patients normalizes regulatory T cells but does not restore CD4
+
T cell proliferation
. Addiction Biology 26:4.
Crossref
Crossref
Noa Krawczyk, Arthur Robin Williams, Brendan Saloner & Magdalena Cerdá. (2021) Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings. Journal of Substance Abuse Treatment 126, pages 108329.
Crossref
Crossref
Suzanne Nielsen, Paul Sanfilippo, Vendula Belackova, Carolyn Day, Ed Silins, Nicholas Lintzeris, Raimondo Bruno, Jason Grebely, Kari Lancaster, Robert Ali, James Bell, Paul Dietze, Louisa Degenhardt, Michael Farrell & Briony Larance. (2020) Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross‐sectional study in three Australian cities. Addiction 116:6, pages 1482-1494.
Crossref
Crossref
Arnaud Godin, Nadine Kronfli, Joseph Cox, Michel Alary & Mathieu Maheu-Giroux. (2021) The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada. International Journal of Drug Policy 88, pages 102738.
Crossref
Crossref
George E. Woody. (2020)
Commentary on Farnum
et al
.: Agonist maintenance in Ukraine—ambivalence, success and moving forward
. Addiction 116:1, pages 94-95.
Crossref
Crossref
Scott O. Farnum, Iuliia Makarenko, Lynn Madden, Alyona Mazhnaya, Ruthanne Marcus, Tanya Prokhorova, Martha J. Bojko, Julia Rozanova, Sergii Dvoriak, Zahedsul Islam & Frederick L. Altice. (2020) The real‐world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine. Addiction 116:1, pages 83-93.
Crossref
Crossref
Tuan Anh Le, Giang Hai Ha, Mai Quynh Thi Le, Lien My Hoang Tran, Duyen Thanh Thi Pham, Ninh Hai Thi Tran, Giang Thu Vu, Long Hoang Nguyen, Hai Quang Pham, Cuong Tat Nguyen, Tung Hoang Tran, Kiet Tuan Huy Pham, Bach Xuan Tran, Carl A. Latkin, Cyrus S. H. Ho & Roger C. M. Ho. (2020) Treatment adherence amongst drug users attending public and private methadone maintenance clinics in a northern province of Vietnam. Substance Abuse Treatment, Prevention, and Policy 15:1.
Crossref
Crossref
Kuen-Hong Wu, Shao-Chiu Juan, Chia-Hsiang Chan, Sun-Yuan Chou & Hung-Yu Chan. (2020) Factors Affecting Changes of Cluster of Differentiation 4 Cell Counts Among Human Immunodeficiency Virus-positive People Who Inject Heroin and Receive Methadone Maintenance Treatment. Journal of Addiction Medicine 14:6, pages e310-e315.
Crossref
Crossref
Micah Piske, Trevor Thomson, Emanuel Krebs, Natt Hongdilokkul, Julie Bruneau, Sander Greenland, Paul Gustafson, M Ehsan Karim, Lawrence C McCandless, Malcolm Maclure, Robert W Platt, Uwe Siebert, M Eugenia Socías, Judith I Tsui, Evan Wood & Bohdan Nosyk. (2020) Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada. BMJ Open 10:9, pages e036102.
Crossref
Crossref
Robert A. Kleinman & Nathaniel P. Morris. (2020) Is It Time to Reschedule Heroin?. JAMA Psychiatry 77:8, pages 781.
Crossref
Crossref
Lara Carson WeinsteinQais IqbalAmy CunninghamRobin DebatesGreg LandistratisPatrick DoggettAlexis Silverio. (2020) Retention of Patients With Multiple Vulnerabilities in a Federally Qualified Health Center Buprenorphine Program: Pennsylvania, 2017–2018. American Journal of Public Health 110:4, pages 580-586.
Crossref
Crossref
Daniel L. Howard. 2020. Effective Prevention and Treatment of Substance Use Disorders for Racial and Ethnic Minorities. Effective Prevention and Treatment of Substance Use Disorders for Racial and Ethnic Minorities.
Tara Carney, Marie Claire Van Hout, Ian Norman, Siphokazi Dada, Nandi Siegfried & Charles DH Parry. (2020) Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Dale Terasaki, Christopher Smith & Susan L. Calcaterra. (2019) Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:10, pages 1023-1029.
Crossref
Crossref
Hannah Fraser, Claudia Vellozzi, Thomas J Hoerger, Jennifer L Evans, Alex H Kral, Jennifer Havens, April M Young, Jack Stone, Senad Handanagic, Susan Hariri, Carolina Barbosa, Matthew Hickman, Alyssa Leib, Natasha K Martin, Lina Nerlander, Henry F Raymond, Kimberly Page, Jon Zibbell, John W Ward & Peter Vickerman. (2019) Scaling Up Hepatitis C Prevention and Treatment Interventions for Achieving Elimination in the United States: A Rural and Urban Comparison. American Journal of Epidemiology 188:8, pages 1539-1551.
Crossref
Crossref
Bao-Liang Zhong, Yan-Min Xu, Wu-Xiang Xie, Jin Lu, Wen-Bo Yu & Jun Yan. (2019) Alcohol Drinking in Chinese Methadone-maintained Clients: A Self-medication for Depression and Anxiety?. Journal of Addiction Medicine 13:4, pages 314-321.
Crossref
Crossref
James Bell, Vendula Belackova & Nicholas Lintzeris. (2018) Supervised Injectable Opioid Treatment for the Management of Opioid Dependence. Drugs 78:13, pages 1339-1352.
Crossref
Crossref
Lynn M. Madden, Scott O. Farnum, Kathryn F. Eggert, Andrew R. Quanbeck, Robert M. Freeman, Samuel A. Ball, Richard S. Schottenfeld, Julia M. Shi, Mary Ellen Savage & Declan T. Barry. (2018) An investigation of an open‐access model for scaling up methadone maintenance treatment. Addiction 113:8, pages 1450-1458.
Crossref
Crossref
Saul Alcaraz, Francisco González-Saiz, Joan Trujols, Esperanza Vergara-Moragues, Núria Siñol & José Pérez de los Cobos. (2018) A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers. Drug and Alcohol Dependence 187, pages 278-284.
Crossref
Crossref
Pulin Liu, Ranran Song, Yao Zhang, Cheng Liu, Bingxi Cai, Xuebing Liu, Jiaoyuan Li, Xueqin Chen, Juntao Ke, Jiao Lou, Wei Chen, Beibei Zhu, Li Zou, Yang Yang, Ying Zhu, Yajie Gong, Rong Zhong & Xiaoping Miao. (2018) Educational and Behavioral Counseling in a Methadone Maintenance Treatment Program in China: A Randomized Controlled Trial. Frontiers in Psychiatry 9.
Crossref
Crossref
Iuliia Makarenko, Alyona Mazhnaya, Ruthanne Marcus, Iryna Pykalo, Lynn Madden, Sergii Filippovich, Sergii Dvoriak & Frederick L. Altice. (2018) Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine. Journal of Substance Abuse Treatment 87, pages 1-8.
Crossref
Crossref
Hannah Fraser, Jon Zibbell, Thomas Hoerger, Susan Hariri, Claudia Vellozzi, Natasha K. Martin, Alex H. Kral, Matthew Hickman, John W. Ward & Peter Vickerman. (2017) Scaling‐up HCV prevention and treatment interventions in rural United States—model projections for tackling an increasing epidemic. Addiction 113:1, pages 173-182.
Crossref
Crossref
Serena Luchenski, Nick Maguire, Robert W Aldridge, Andrew Hayward, Alistair Story, Patrick Perri, James Withers, Sharon Clint, Suzanne Fitzpatrick & Nigel Hewett. (2018) What works in inclusion health: overview of effective interventions for marginalised and excluded populations. The Lancet 391:10117, pages 266-280.
Crossref
Crossref
Kanna Hayashi, Lianping Ti, Prempreeda Pramoj Na Ayutthaya, Paisan Suwannawong, Karyn Kaplan, Will Small & Thomas Kerr. (2017) Barriers to retention in methadone maintenance therapy among people who inject drugs in Bangkok, Thailand: a mixed-methods study. Harm Reduction Journal 14:1.
Crossref
Crossref
Julia Rozanova, Ruthanne Marcus, Faye S. Taxman, Martha J. Bojko, Lynn Madden, Scott O. Farnum, Alyona Mazhnaya, Sergii Dvoriak & Frederick L. Altice. (2017) Why People Who Inject Drugs Voluntarily Transition Off Methadone in Ukraine. Qualitative Health Research 27:13, pages 2057-2070.
Crossref
Crossref
Jemima A. Frimpong, Karen Shiu‐Yee & Thomas D'Aunno. (2016) The Role of Program Directors in Treatment Practices: The Case of Methadone Dose Patterns in U.S. Outpatient Opioid Agonist Treatment Programs. Health Services Research 52:5, pages 1881-1907.
Crossref
Crossref
Kostyantyn Dumchev, Sergii Dvoryak, Olena Chernova, Olga Morozova & Frederick L. Altice. (2017) Retention in medication-assisted treatment programs in Ukraine—Identifying factors contributing to a continuing HIV epidemic. International Journal of Drug Policy 48, pages 44-53.
Crossref
Crossref
Christine M. Wilder, Daniel Hosta & Theresa Winhusen. (2017) Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder. Journal of Substance Abuse Treatment 80, pages 33-36.
Crossref
Crossref
Martin Aigner. (2017) Opioide in der SubstitutionsbehandlungOpioids in Substitution Treatment. psychopraxis. neuropraxis 20:4, pages 162-164.
Crossref
Crossref
Christinah Mukandavire, Andrea Low, Gitau Mburu, Adam Trickey, Margaret T. May, Charlotte F. Davies, Clare E. French, Katharine J. Looker, Tim Rhodes, Lucy Platt, Andy Guise, Matthew Hickman & Peter Vickerman. (2017) Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs. AIDS 31:8, pages 1181-1190.
Crossref
Crossref
Joan Trujols, Francisco González-Saiz, María José Manresa, Saul Alcaraz, Francesca Batlle, Santiago Duran-Sindreu & José Pérez de los Cobos. (2017) Patient perception of methadone dose adequacy in methadone maintenance treatment: The role of perceived participation in dosage decisions. Patient Education and Counseling 100:5, pages 981-986.
Crossref
Crossref
Jessica F. Magidson, Hetta Gouse, Warren Burnhams, Christie Y.Y. Wu, Bronwyn Myers, John A. Joska & Adam W. Carrico. (2017) Beyond methamphetamine: Documenting the implementation of the Matrix model of substance use treatment for opioid users in a South African setting. Addictive Behaviors 66, pages 132-137.
Crossref
Crossref
Kathleen Broad & Tony P. George. 2017. Mental Disorders in Primary Care. Mental Disorders in Primary Care
201
215
.
Xiaofeng Luo, Xiao Gong, Peizhen Zhao, Xia Zou, Wen Chen & Li Ling. (2017) Re-entry and related predictors among HIV-infected clients receiving methadone maintenance treatment in Guangdong province, China. BioScience Trends 11:3, pages 282-291.
Crossref
Crossref
Bo Zhang, Thomas Cai, Zhihua Yan, Gitau Mburu, Bangyuan Wang & Liping Yang. (2016) Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China. Harm Reduction Journal 13:1.
Crossref
Crossref
Marie Claire Van Hout, Ide Delargy, Gerry Ryan, Siobhan Flanagan & Hugh Gallagher. (2015) Dependence on Over the Counter (OTC) Codeine Containing Analgesics: Treatment and Recovery with Buprenorphine Naloxone. International Journal of Mental Health and Addiction 14:5, pages 873-883.
Crossref
Crossref
Mahmood Sheikh Fathollahi, Fateme Torkashvand, Hamid Najmeddin & Mohsen Rezaeian. (2016) Predictors of One-Year Retention in Methadone Maintenance Treatment (MMT) in Iran, Rafsanjan. International Journal of High Risk Behaviors and Addiction 5:3.
Crossref
Crossref
Martha J. Bojko, Alyona Mazhnaya, Ruthanne Marcus, Iuliia Makarenko, Zahedul Islam, Sergey Filippovych, Sergii Dvoriak & Frederick L. Altice. (2016) The Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment. Journal of Substance Abuse Treatment 66, pages 37-47.
Crossref
Crossref
Tara Carney, Marie Claire Van Hout, Ian Norman, Siphokazi Dada & Charles DH Parry. (2016) Dihydrocodeine for detoxification and maintenance treatment in illicit opiate-dependent individuals. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Omary Ubuguyu, Olivia C. Tran, Robert Douglas Bruce, Frank Masao, Cassian Nyandindi, Norman Sabuni, Sheryl McCurdy, Jessie Mbwambo & Barrot H. Lambdin. (2016) Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam, Tanzania. International Journal of Drug Policy 30, pages 74-81.
Crossref
Crossref
Georgios Kourounis, Brian David Wensley Richards, Evdokia Kyprianou, Eva Symeonidou, Minerva-Melpomeni Malliori & Lampros Samartzis. (2016) Opioid substitution therapy: Lowering the treatment thresholds. Drug and Alcohol Dependence 161, pages 1-8.
Crossref
Crossref
Xiaofeng Luo, Peizhen Zhao, Xiao Gong, Lei Zhang, Weiming Tang, Xia Zou, Wen Chen & Li Ling. (2016) Concurrent Heroin Use and Correlates among Methadone Maintenance Treatment Clients: A 12-Month Follow-up Study in Guangdong Province, China. International Journal of Environmental Research and Public Health 13:3, pages 305.
Crossref
Crossref
Leen NajiBrittany B. DennisMonica BaworCarolyn PlaterGuillaume PareAndrew WorsterMichael VarenbutJeff DaiterDavid C. MarshDipika DesaiLehana ThabaneZainab Samaan. (2016) A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone. Substance Abuse: Research and Treatment 10, pages SART.S37030.
Crossref
Crossref
Jiucheng Shen, Mei Wang, Xiaodan Wang, Guanbai Zhang, Jie Guo, Xinyue Li & Jianhua Li. (2016) Predictors of Poor Adherence to Methadone Maintenance Treatment in Yunnan Province, China. Journal of Addiction Medicine 10:1, pages 40-45.
Crossref
Crossref
Monica Bawor, Brittany B. Dennis, Charlie Tan, Guillaume Pare, Michael Varenbut, Jeff Daiter, Carolyn Plater, Andrew Worster, David C. Marsh, Meir Steiner, Rebecca Anglin, Dipika Desai, Lehana Thabane & Zainab Samaan. (2015) Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study. Addiction Science & Clinical Practice 10:1.
Crossref
Crossref
Tsz Ho Kwan, Ngai Sze Wong & Shui Shan Lee. (2015) Participation dynamics of a cohort of drug users in a low-threshold methadone treatment programme. Harm Reduction Journal 12:1.
Crossref
Crossref
Stuart Gore, Julio Mendoza & Jaime Delgadillo. (2015) Multiple obstacles to psychological care from the viewpoint of addiction service users. Advances in Dual Diagnosis 8:3, pages 129-140.
Crossref
Crossref
Amanda R. Levine, Leslie H. Lundahl, David M. Ledgerwood, Michael Lisieski, Gary L. Rhodes & Mark K. Greenwald. (2015) Gender-Specific Predictors of Retention and Opioid Abstinence During Methadone Maintenance Treatment. Journal of Substance Abuse Treatment 54, pages 37-43.
Crossref
Crossref
Shujun Pan, Haifeng Jiang, Jiang Du, Hanhui Chen, Zhibin Li, Walter Ling & Min Zhao. (2015) Efficacy of Cognitive Behavioral Therapy on Opiate Use and Retention in Methadone Maintenance Treatment in China: A Randomised Trial. PLOS ONE 10:6, pages e0127598.
Crossref
Crossref
Olivia C. Tran, Robert Douglas Bruce, Frank Masao, Omary Ubuguyu, Norman Sabuni, Jessie Mbwambo & Barrot H. Lambdin. (2015) Implementation and Operational Research. JAIDS Journal of Acquired Immune Deficiency Syndromes 69:2, pages e43-e48.
Crossref
Crossref
Christine Wilder, Daniel Lewis & Theresa Winhusen. (2015) Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Drug and Alcohol Dependence 149, pages 225-231.
Crossref
Crossref
D. Werb, K.D. Wagner, L. Beletsky, Patricia Gonzalez-Zuniga, Gudelia Rangel & S.A. Strathdee. (2015) Police bribery and access to methadone maintenance therapy within the context of drug policy reform in Tijuana, Mexico. Drug and Alcohol Dependence 148, pages 221-225.
Crossref
Crossref
B. H. Lambdin, F. Masao, O. Chang, P. Kaduri, J. Mbwambo, A. Magimba, N. Sabuni & R. D. Bruce. (2014) Methadone Treatment for HIV Prevention--Feasibility, Retention, and Predictors of Attrition in Dar es Salaam, Tanzania: A Retrospective Cohort Study. Clinical Infectious Diseases 59:5, pages 735-742.
Crossref
Crossref
Carlos Isaza, Julieta Henao, Juan Velez, Miguel A. Rodríguez, Juan Sierra, Leonardo Beltrán & Ana Sepúlveda. (2014) Evaluación del programa de mantenimiento con metadona del Hospital Mental de Risaralda. Revista Colombiana de Psiquiatría 43:2, pages 96-105.
Crossref
Crossref
Brittany B. Dennis, Monica Bawor, Lehana Thabane, Zahra Sohani & Zainab Samaan. (2014) Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis. PLoS ONE 9:1, pages e86114.
Crossref
Crossref
Thomas A. Nguyen, Jennie H. Hahn & Stephen M. Strakowski. (2013) Pharmacotherapies for treating opioid use disorder. CNS Spectrums 18:6, pages 289-295.
Crossref
Crossref
Sheena G. Sullivan, Zunyou Wu & Roger Detels. (2013) Time to first treatment interruption in the Chinese methadone maintenance treatment programme. Drug and Alcohol Dependence 133:2, pages 427-432.
Crossref
Crossref
Louis E. Baxter, Anthony Campbell, Michael DeShields, Petros Levounis, Judith A. Martin, Laura McNicholas, J. Thomas Payte, Edwin A. Salsitz, Trusandra Taylor & Bonnie B. Wilford. (2013) Safe Methadone Induction and Stabilization. Journal of Addiction Medicine 7:6, pages 377-386.
Crossref
Crossref
Justin J. Sanders, Robert J. Roose, Michael C. Lubrano & Sean C. Lucan. (2013) Meaning and Methadone. Journal of Addiction Medicine 7:5, pages 307-313.
Crossref
Crossref
Lei Zhang, Eric P. F. Chow, Xun Zhuang, Yanxian Liang, Yafei Wang, Caiyun Tang, Li Ling, Joseph D. Tucker & David P. Wilson. (2013) Methadone Maintenance Treatment Participant Retention and Behavioural Effectiveness in China: A Systematic Review and Meta-Analysis. PLoS ONE 8:7, pages e68906.
Crossref
Crossref
Bach Xuan Tran, Arto Ohinmaa, Steve Mills, Anh Thuy Duong, Long Thanh Nguyen, Philip Jacobs & Stan Houston. (2012) Multilevel Predictors of Concurrent Opioid Use during Methadone Maintenance Treatment among Drug Users with HIV/AIDS. PLoS ONE 7:12, pages e51569.
Crossref
Crossref
Hsin-Ya Lee, Jih-Heng Li, Li-Tzy Wu, Jin-Song Wu, Cheng-Fang Yen & Hsin-Pei Tang. (2012) Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. Substance Abuse Treatment, Prevention, and Policy 7:1.
Crossref
Crossref
Hajar Shekarchizadeh, Hamed Ekhtiari, Mohammad R Khami & Jorma I Virtanen. (2012) Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduction Journal 9:1.
Crossref
Crossref
Peter Vickerman, Natasha Martin, Katy Turner & Matthew Hickman. (2012)
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis
C
virus prevalence? Model projections for different epidemic settings
. Addiction 107:11, pages 1984-1995.
Crossref
Crossref
Jing Gu, Huifang Xu, Joseph T. F. Lau, Yuantao Hao, Ying Zhong, Lirui Fan, Yuteng Zhao, Chun Hao & Wenhua Ling. (2012) Misconceptions predict dropout and poor adherence prospectively among newly admitted first‐time methadone maintenance treatment clients in Guangzhou, China. Addiction 107:9, pages 1641-1649.
Crossref
Crossref
Julie Harris & Karen McElrath. (2012) Methadone as Social Control. Qualitative Health Research 22:6, pages 810-824.
Crossref
Crossref
Tam T. M. Nguyen, Long T. Nguyen, Manh D. Pham, Hoang H. Vu & Kevin P. Mulvey. (2012) Methadone Maintenance Therapy in Vietnam: An Overview and Scaling-Up Plan. Advances in Preventive Medicine 2012, pages 1-5.
Crossref
Crossref
Jessica De Maeyer, Wouter Vanderplasschen, Laura Camfield, Stijn Vanheule, Bernard Sabbe & Eric Broekaert. (2011) A good quality of life under the influence of methadone: A qualitative study among opiate-dependent individuals. International Journal of Nursing Studies 48:10, pages 1244-1257.
Crossref
Crossref
Chunqing Lin & Roger Detels. (2011) A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China. Drug and Alcohol Dependence 117:1, pages 45-49.
Crossref
Crossref
Melinda Campopiano. (2010) Methadone maintenance therapy in the United States: a case example of dual diagnosis. Advances in Dual Diagnosis 3:3, pages 11-16.
Crossref
Crossref
Philipp Lobmaier, Michael Gossop, Helge Waal & Jorgen Bramness. (2010) The pharmacological treatment of opioid addiction—a clinical perspective. European Journal of Clinical Pharmacology 66:6, pages 537-545.
Crossref
Crossref
YANHUA CHE, SAWITRI ASSANANGKORNCHAI, EDWARD MCNEIL, VIRASAKDI CHONGSUVIVATWONG, JIANHUA LI, ALAN GEATER & JING YOU. (2010) Predictors of early dropout in methadone maintenance treatment program in Yunnan province, China. Drug and Alcohol Review 29:3, pages 263-270.
Crossref
Crossref
Gez Bevan. (2009) Problem drug use the public health imperative: what some of the literature says. Substance Abuse Treatment, Prevention, and Policy 4:1.
Crossref
Crossref
Didier Jutras-AswadM.D. M. ScM.D. M. Sc, Julie BruneauM.D. M. ScM.D. M. Sc & Yasmin L. HurdPh. D.Ph. D.. (2010) Neurobiologie de la toxicomanie : avancées récentes et nouvelles stratégies d’intervention. Drogues, santé et société 8:2, pages 27-73.
Crossref
Crossref